Current landscape of therapeutic resistance in lung cancer and promising strategies to overcome resistance
… mechanisms of therapeutic resistance is important in … lung cancer patients. In this review,
we discuss the mechanisms underlying the acquisition of resistance to different lines of therapy …
we discuss the mechanisms underlying the acquisition of resistance to different lines of therapy …
Basic mechanisms of therapeutic resistance to radiation and chemotherapy in lung cancer
H Willers, CG Azzoli, WL Santivasi, F Xia - The Cancer Journal, 2013 - journals.lww.com
… of human cancers including lung cancer. Defects … lung tumors to radiation therapy. Here,
we will review clinically relevant mechanisms affecting resistance and sensitivity of lung cancer …
we will review clinically relevant mechanisms affecting resistance and sensitivity of lung cancer …
Drug resistance to targeted therapeutic strategies in non-small cell lung cancer
… resistance mechanisms in NSCLC targeted therapies, namely changes in the targeted
oncogenes (on-target resistance) … Therapeutic resistance limits the clinical use of chemotherapy …
oncogenes (on-target resistance) … Therapeutic resistance limits the clinical use of chemotherapy …
Resisting resistance: targeted therapies in lung cancer
JJ Lin, AT Shaw - Trends in cancer, 2016 - cell.com
… heterogeneous nature of TKI resistance, which evolves dynamically with changes in therapy.
In this … the diverse mechanisms of resistance at play in oncogene-driven lung cancers. …
In this … the diverse mechanisms of resistance at play in oncogene-driven lung cancers. …
Novel third-generation EGFR tyrosine kinase inhibitors and strategies to overcome therapeutic resistance in lung cancer
… % of patients with non–small cell lung cancer. Tyrosine kinase inhibitors have provided an
… in cancer and the role of tumor-specific adaptations conferring therapeutic resistance. The …
… in cancer and the role of tumor-specific adaptations conferring therapeutic resistance. The …
Therapeutic resistance in lung cancer
A Nadkar, C Pungaliya, K Drake, E Zajac… - Expert Opinion on …, 2006 - Taylor & Francis
… therapy of lung cancer, intrinsic and acquired resistance to … of mechanisms of therapeutic
resistance in lung cancer has … the crucial role of stress resistance pathways is increasingly …
resistance in lung cancer has … the crucial role of stress resistance pathways is increasingly …
A study of miRNAs as cornerstone in lung cancer pathogenesis and therapeutic resistance: A focus on signaling pathways interplay
… Lung cancer (LC) is one of the most frequently diagnosed malignancies and the leading
cause of cancer-related deaths in … Drug resistance has become a significant impediment to the …
cause of cancer-related deaths in … Drug resistance has become a significant impediment to the …
Causative role of PDLIM2 epigenetic repression in lung cancer and therapeutic resistance
… for lung cancer therapeutic responses. While PDLIM2 is epigenetically repressed in human
lung cancer, associating with therapeutic resistance and poor prognosis, its global or lung …
lung cancer, associating with therapeutic resistance and poor prognosis, its global or lung …
Drug resistance in lung cancer
M Shanker, D Willcutts, JA Roth… - Lung Cancer: Targets …, 2010 - Taylor & Francis
… resistance in lung cancer. Non-small cell lung cancer (NSCLC) cells are often intrinsically
resistant … , whereas small-cell lung cancer (SCLC) cells can acquire resistance with continued …
resistant … , whereas small-cell lung cancer (SCLC) cells can acquire resistance with continued …
Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy
ZF Lim, PC Ma - Journal of hematology & oncology, 2019 - Springer
… drug resistance. We attempt to summarize the gap in knowledge in understanding acquired
resistance to early-phase lung cancer targeted therapy … and early adaptive drug resistance. …
resistance to early-phase lung cancer targeted therapy … and early adaptive drug resistance. …
相关搜索
- chemotherapy in lung cancer therapeutic resistance
- non-small cell lung cancer therapeutic targets
- lung cancer drug resistance
- lung cancer cells
- lung cancer egfr tyrosine kinase inhibitors
- lung cancer targeted therapy
- mirnas in lung cancer
- lung cancer oncogenic drivers
- lung cancer resistance mechanisms
- lung cancer pathogenesis therapeutic resistance
- cisplatin resistant lung cancer
- therapeutic relevance microrna in lung cancer
- cell lung cancer patients resistance mechanisms
- small cell lung cancer multi-drug resistance
- rlip76 in lung cancer doxorubicin resistance
- lung cancer doxorubicin resistance atpase activity